CHERISH: Upper limb function results

SPINRAZA® patients demonstrate improvement in upper limb function1

  • At the final analysis, patients treated with SPINRAZA® experienced a greater improvement in RULM score versus sham-control patients (p=0.0000001)*1

Change in RULM score1

Scheme
Scheme

*Nominal p-value.

Banner
Banner

Ruby
age 6 years*
Later-onset (Type II) SMA
treated with SPINRAZA®
~4 years as of 9/18

*Age at time of photo shoot.

References:
1. SPINRAZA® Summary of Product Characteristics.